In Model 1, SHBG levels were significantly associated with the presence of dyslipidemia (ORs: 0.757, 95% CIs: [0.610–0.934], P = 0.010), whereas in Model 2, this association was not significant (ORs: 0.786, 95% CIs: [0.591–1.036], P = 0.092). Here, SHBG is linked to metabolic syndrome.